Stock comparison
Mycronic AB (publ)
MYCR.ST$59.56BIndustrials Market cap, Sector
SPX Technologies
SPXC$12.16BIndustrials Market cap, Sector
Overall winner
Mycronic AB (publ)
MYCR.ST 70 SPXC
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
MYCR.ST7wins
0winsSPXC
77B
D49
85A
B76
85A
D45
69C
F27
66C
F44
78B
F44
77B
F41
Side-by-side metrics
| Metric | MYCR.ST | SPXC |
|---|---|---|
| Market cap | Winner: $59.56B | $12.16B |
| P/E (TTM) | Winner: 37.5x | 39.1x |
| EV/EBIT | 29.1x | 28.0x Winner |
| ROIC (TTM) | Winner: 20.79% | 9.15% |
| Gross margin | Winner: 52.44% | 36.67% |
| Net margin | Winner: 19.65% | 11.06% |
| Revenue CAGR 5y | 15.75% | 16.74% Winner |
| EPS CAGR 5y | Winner: 28.15% | -14.03% |
| Debt / Equity | Winner: 0.0x | 0.3x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MYCR.ST leads on
- EPS CAGR 5y28.15%vs -14.03%+150%
- Debt / Equity0.0xvs 0.3x+83%
- Market cap$59.56Bvs $12.16B+80%
- ROIC (TTM)20.79%vs 9.15%+56%
SPXC leads on
- Revenue CAGR 5y16.74%vs 15.75%+6%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.